Looking For a Template for your CER ?
Get it here!Looking for Regulatory Consultant ?
Bringing a medical device to the US market requires understanding a complex regulatory framework. One of the most common routes is the 510(k) submission, a critical part of the FDA submission process. Maven supports medical device manufacturers in ensuring their products meet the safety, security, and compliance standards required by the 510(k) submission process.
Explore this comprehensive guide to understand the 510(k) FDA submission, who must submit it, the benefits, and how Maven Profcon Services can support your regulatory journey.
According to the FDA’s guidance on Premarket Notification 510(k), a 510(k) submission is required for most medical devices intended for human use that are not subject to premarket approval (PMA). This includes:
It’s important to note that some devices may be exempt from the 510(k) submission process. For instance, certain Class I and Class II devices are exempt from premarket notification requirements. However, even if exempt from 510(k) requirements, these devices must still comply with other regulatory controls unless specifically exempted.
Before manufacturers begin the 510(k) submission process, they must determine substantial equivalence. This means the new device has the same intended use and similar technological characteristics as an existing legally marketed device.
Establishing substantial equivalence helps the Notified Body ensure the new device does not raise new safety or effectiveness concerns, making this the cornerstone of every 510(k) FDA submission.
The FDA’s Pre-Submission (Pre-Sub) process is a voluntary opportunity for medical device manufacturers to engage with the FDA before submitting a 510(k) application. While not mandatory, it offers several advantages:
Feedback from the FDA during the Pre-Sub process is non-binding but provides valuable insights into the FDA’s expectations. Manufacturers should carefully consider this feedback to align their final submission with regulatory requirements.
The FDA requires certain parties to submit a 510(k) submission when introducing medical devices to the US market. These include:
Additionally, manufacturers of Class II, III, and some Class I devices must follow design controls and maintain documentation per FDA requirements. Any significant device changes may require a new 510(k) submission following quality system regulations.
Navigating the 510(k) submission process may seem overwhelming, but breaking it down into clear steps can ease the journey. Each phase involves collecting specific data and coordinating with the Authorities.
Finding a predicate device is the first critical step. It helps define the regulatory pathway by identifying the following:
This search sets the foundation for your 510(k) submission strategy.
Once a predicate is identified, the next task is choosing the submission type:
This is the most common format and includes complete supporting data like lab tests, risk analyses, and device descriptions.
Used when a manufacturer modifies its own legally marketed device, provided the changes don’t affect safety or effectiveness.
This utilizes existing FDA guidance, special controls, or recognized consensus standards, streamlining the FDA submission process.
The submission file is the core of your 510(k) submission. It includes:
The file must comply with all 510(k) submission requirements, including labeling, device photos, and proposed indications.
Before proceeding, applicants must pay the FDA user fee. For 2025, the annual establishment registration fee is set at $9,280, with no reductions available for small establishments, businesses, or groups during this fiscal year.
The FDA submission process begins once the file is submitted via the Center for Devices and Radiological Health’s (CDRH) Electronic Submission Template. The FDA then conducts an initial acceptance review, followed by substantive and interactive reviews.
Communication during this stage is essential to meet the 510(k) submission process timelines.
If the submission is approved, the FDA issues a 510(k) clearance letter. This allows the device to be marketed in the US. If deficiencies exist, a request for additional information will be issued.
Maven supports manufacturers through the complete 510(k) submission process, ensuring accuracy and compliance at every stage. Here’s how Maven adds value:
Maven understands that a 510(k) submission is an ongoing document cycle rather than a single event. By understanding the FDA submission process, knowing the 510k submission requirements, and working with experts like Maven, manufacturers can streamline compliance and market entry.
Let us guide you through every detail of your FDA 510(k) submission, from strategy to decision letter, ensuring your device meets the standards for safety, security, and effectiveness.
Start with a thorough device classification and predicate search. Engage in pre-submission meetings and develop detailed technical documentation that meets all 510(k) submission requirements.
Q-submissions must be filed electronically through the FDA’s eSTAR system. The FDA’s CDRH handles these communications.
These tests show how well a device performs under expected conditions. Providing complete and validated test data during your FDA 510(k) submission helps reviewers determine substantial equivalence more efficiently.
While timelines vary, most 510(k) FDA submissions are reviewed within 90 days. However, interaction phases and requests for additional information may extend the timeline.
Yes. A submitter can request to withdraw a 510(k) submission at any time before the decision letter is issued. This may be done if new data is needed or a different regulatory pathway is chosen.
Costs vary based on testing, consulting, and filing fees. The fees for submission include the following:
Connect With Us